This age is worth noting not as a superlative — the youngest chemist ever to do anything, a category that always has exceptions — but because it places her achievement in its educational and institutional context. She had been in higher education for three years as an undergraduate and one year in a master’s program. She had the equivalent of about four years of post-secondary training in pharmaceutical chemistry and pharmacy. She was not an established researcher with decades of experience; she was a very recent graduate student who had just finished her thesis on a different problem entirely.
The chaulmoogra problem Hollmann brought to her was not a simple extension of her thesis. It required her to apply her training to a new set of compounds and a new set of medical constraints, working toward a practical formulation rather than a theoretical characterization. That she was able to do this effectively within what appears to have been months of work — the research was conducted in 1915, and she became ill later that year or in early 1916 — is a measure of both her ability and the thoroughness of her preparation.
Young researchers solving longstanding medical problems is not unknown in the history of science, but it is not common either. The combination of the right training, the right timing, and the right problem produced a result that people with far more experience had not been able to produce. Dean was at the institution for years before Ball arrived; Hollmann had been working on the chaulmoogra problem for some time before he brought it to the chemistry department. What Ball contributed was the specific chemical approach — the ethyl ester strategy — and the laboratory execution to make it work.
